Facility Details

UC Davis’ Institute for Regenerative Cures offers leading-edge research services for Investigational New Drug (IND) development. Located in Sacramento and anchored by Northern California’s largest academic Good Manufacturing Practice facility, the institute’s fee-for-service cores and support services include pre-clinical transplantation assays in immune deficient mouse models, as well as an ability to scale-up manufacturing processes for novel cell and gene therapies. From bench to bedside, UC Davis can meet research needs with affordable services for investigators, including external academic and industry partners.